Status:
UNKNOWN
Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Treatment
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Conditions:
Lung Cancer, Small Cell
Pancreatic Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Accurate evaluation of activity status is an important part of the assessment of people with cancer. Clinician assessments currently used are valuable but have limitations; in particular, assessment o...
Detailed Description
A recent metanalysis reports that over 40% of people with cancer being treated with palliative intent have at least 1 unplanned hospital admission during treatment. Furthermore, up to 83% of people un...
Eligibility Criteria
Inclusion
- Age \>/= 18.
- Advanced lung (NSCLC or SCLC) cancer or patients with upper gastrointestinal cancer (gastric, oesophageal, pancreatic) starting a new line of systemic anti-cancer therapy.
- Willingness to wear an activity tracker and undergo remote monitoring
- Access to a smart phone.
- Willingness to have a Fitbit App installed on their smartphone
- Willingness to have a pseudo- anonymised FitBit account created for the purposes of the study
- PS 0-2.
- 1 or more previous lines of treatment.
Exclusion
- Physical conditions that preclude daily walking
- Inability to give informed consent.
- Medical or psychiatric condition which in the investigators opinion would affect the successful completion of the study.
- Immediate need to start systemic anticancer therapy
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04440800
Start Date
July 1 2020
End Date
September 1 2021
Last Update
June 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Marsden NHS Foundation Trust - London and Surrey
London, United Kingdom, SM2 5PT